Emergent Biotechnologies LLC

UEI
EV7KDUPEBLS2
CAGE
836W2
Primary NAICS
Not on record
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Limited Liability Company
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Emergent Biotechnologies LLC's 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Novel therapy for preeclampsia - novel therapy for preeclampsia abstract preeclampsia (pree) is a serious complication… Grant · R43HD106857 National Institute of Child Health and Human Development $769,916
Anti-fibrotic therapy for primary sclerosing cholangitis Grant · R43DK122874 National Institute of Diabetes and Digestive and Kidney Diseases $225,722

Quick answers

What is Emergent Biotechnologies LLC's UEI?

Emergent Biotechnologies LLC's Unique Entity ID (UEI) in SAM.gov is EV7KDUPEBLS2.

What is Emergent Biotechnologies LLC's CAGE code?

Emergent Biotechnologies LLC's CAGE code is 836W2.

Is Emergent Biotechnologies LLC registered in SAM.gov?

Emergent Biotechnologies LLC's SAM.gov registration expired on February 7, 2023.

What is Emergent Biotechnologies LLC's most recent federal award?

Emergent Biotechnologies LLC's most recent federal grant award is Novel therapy for preeclampsia - novel therapy for preeclampsia abstract preeclampsia (pree) is a serious complication… (R43HD106857), from National Institute of Child Health and Human Development, on September 1, 2022.

On GovTribe

See Emergent Biotechnologies LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login